Paraneoplastic sensorimotor neuropathy, neural autoantibody positive (Q100996)

From determinar.ia.br - Determine suas informações
Revision as of 17:47, 16 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Paraneoplastic sensorimotor neuropathy occurs as a remote effect in cancer and lymphoma patients in an undetermined frequency. It is an uncharacteristic sensorimotor neuropathy with mixed motor and sensory component also with a large variance of clinical expression. The neuropathy can occur at the first presentation of the cancer, or appear in the later course, where it has to be distinguished from treatment toxicity, sequelae of weight loss and hypovitaminosis. The association with onconeural antibodies as biomarkers is poor and most commonly related to autoantibodies anti-Hu and anti-CV2/CRMP-5 (collapsin response mediator protein 5) antibodies.
Language Label Description Also known as
default for all languages
ID_1471347177
    English
    Paraneoplastic sensorimotor neuropathy, neural autoantibody positive
    Paraneoplastic sensorimotor neuropathy occurs as a remote effect in cancer and lymphoma patients in an undetermined frequency. It is an uncharacteristic sensorimotor neuropathy with mixed motor and sensory component also with a large variance of clinical expression. The neuropathy can occur at the first presentation of the cancer, or appear in the later course, where it has to be distinguished from treatment toxicity, sequelae of weight loss and hypovitaminosis. The association with onconeural antibodies as biomarkers is poor and most commonly related to autoantibodies anti-Hu and anti-CV2/CRMP-5 (collapsin response mediator protein 5) antibodies.

      Statements

      CID11:ID_1471347177
      0 references
      dki-india-ID_1471347177
      0 references
      Concluído
      0 references
      15 August 2026
      0 references